Wendy Luo

Wendy Luo, M.S., is our Head of Research. With 25 years of experience in Pharma/Biotech companies, her role is to lead GEn1E Lifesciences’ efforts toward the goal of curing inflammation and age-related diseases. Her most recent working experience was Sr. Director at CohBar Inc, focusing on product candidates for the potential treatment of diseases of aging, including NASH, obesity and Type 2 diabetes. Previously, she was Sr. Director of Bioanalytical & QC at XenoPort Inc. In this role, she contributed to drug discovery, preclinical and clinical development across the XenoPort pipeline, including two New Drug Applications (NDAs) and four programs which entered clinical trials. Her experience prior to XenoPort includes technical positions in Applied Biosystems and Allergan Inc. Ms. Luo received her M.S. in Chemistry from Arizona State University and her B.S. degree from Fudan University School of Pharmacy.